The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis

International Journal of Rheumatic Diseases

Volumn 15, Issue 2, 2012, Pages 183-187

  Liu, Yang ^a   Ho, Roger Chun Man ^a   Mak, Anselm ^b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Anxiety; Depression; IL 17; Proinflammatory cytokines; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEPRESSION; DISEASE ACTIVITY; DISEASE ACTIVITY SCALE 28; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANK SUM TEST; RHEUMATOID ARTHRITIS; VISUAL ANALOG SCALE;

ANXIETY DISORDERS; ARTHRITIS, RHEUMATOID; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HEALTH STATUS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; JOINTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SINGAPORE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859264859     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01673.x     Document Type: Article

References (18)

1. Konuk N, Tekin IO, Ozturk U, et al. (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007ID65704, 1-5.
2. Yang K, Xie G, Zhang Z, et al. (2007) Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust N Z J Psychiatry41, 266-73.
3. Dowlati Y, Herrmann N, Swardfager W, et al. (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry67, 446-57.
4. Vieira MM, Ferreira TB, Pacheco PA, et al. (2010) Enhanced Th17 phenotype in individuals with generalized anxiety disorder. J Neuroimmunol229, 212-8.
5. Marie WH, Helena EH, Per L, Lars K (2002) Cytokines in human rheumatoid and murine models. In: Vijay KK, Nora S, David AH (eds) Cytokines and Autoimmune Diseases, pp 371-54. Humana Press, Totowa, NJ, US.
6. Sheehy C (2006) Depression in rheumatoid arthritis. Rheumatology45, 1325-7.
7. Dickens C, McGowan L, Clark-Carter D, Creed F (2008) Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychol Med64, 52-60.
8. Lowe B, Willand L, Eich W, et al. (2007) Psychiatric comorbidity and work disability in patients with inflammatory rheumatic disease. Psychosom Med66, 395-402.
9. Ho RC, Fu EH, Chua AN, Cheak AA, Mak A (2011) Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis. Int J Rheum Dis14, 37-47.
10. Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum31, 315-24.
11. Pincus T, Griffith J, Pearce S, Isenberg D (1996) Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol35, 879-83.
12. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand67, 361-70.
13. Hisakata Y (2010) Current perspectives on the role of IL-17 in autoimmune disease. J Inflammation Res3, 33-44.
14. Barros PO, Ferreira TB, Vieira MM, et al. (2010) Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition. J Clin Immunol31, 51-9.
15. Allan IB, Thomas MJ (2000) The perception of pain. In: Eric RK, James HS, Thomas MJ (eds) Principles of Neural Science, 4th edn, pp 472-91. McGraw-Hill Companies Inc., New York.
16. McHugh SB, Deacon RM, Rawlins JN, Bannerman DM (2004) Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci118, 63-78.
17. Maes M, Lin AH, Delmeire L, et al. (1999) Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry45, 833-9.
18. Brambilla F, Perna G, Bellodi L, et al. (1997) Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry42, 976-81.